Detection and management of latent tuberculosis infections before biologic therapy for psoriasis

A case of lung tuberculosis in a patient with rheumatoid arthritis treated with infliximab after antituberculosis chemoprophylaxis with isoniazid

(2014) Yuji Hirano et al.   Modern Rheumatology

Systematic Review: T-Cell–based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update

(2013) Madhukar Pai et al.   ANNALS OF INTERNAL MEDICINE

Within-Subject Variability and Boosting of T-Cell Interferon-γ Responses after Tuberculin Skin Testing

(2009) Richard N. van Zyl-Smit et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

(2009) W. G. Dixon et al.   ANNALS OF THE RHEUMATIC DISEASES

Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area

(2009) Léia C. R. Silva et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry

(2009) F. Tubach et al.   ARTHRITIS AND RHEUMATISM

British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009

(2009) C.H. Smith et al.   BRITISH JOURNAL OF DERMATOLOGY

Performance of Tests for Latent Tuberculosis in Different Groups of Immunocompromised Patients

(2009) Luca Richeldi et al.   CHEST

Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial

(2008) J Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

A PEGylated Fab′ Fragment against Tumor Necrosis Factor for the Treatment of Crohn Disease

(2008) Tim Bourne et al.   BIODRUGS

QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases

(2008) F. Bartalesi et al.   EUROPEAN RESPIRATORY JOURNAL

National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents

(2008) Sean D. Doherty et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Tumour necrosis factor antagonists: structure, function, and tuberculosis risks

(2008) Robert S Wallis   LANCET INFECTIOUS DISEASES